% | $
Quotes you view appear here for quick access.

Celgene Corp. (CELG) Message Board

  • rob_cos rob_cos Nov 16, 2012 1:48 PM Flag

    Positive CELG comments from weekly video

    Pretty positive comments on CELG from ISI friday video just out....

    ISI made call to own CELG into Pancreatic Cancer Data (which came early) and others did as well – and that was the problem – the stock went up nicely on that great data – but it appears a lot of the money in that stock was in it for a short term trade on the Abraxane data and those folks cleared out especially with the overall biotech tape weak past few weeks (stronger today)/
    But let me be clear – this is going to add a $billion a yr to CELG P&L that wasn’t in there – and that’s a billion $ of very, very high operating margin dollars, 70%-80%.
    This is going to add at least $1 to the EPS of CELG – this is very, very good news.
    MM-020 Front Line Revlimid Myeloma data in Q1 is next key big event. “Binary event”
    “But the key to CELG is not only Revlimid – the key is the rest of the pipeline.
    Epitomized by Apremilast – PsA data out –- Apremilast for dermatology is going to be very interesting - we have been doing some community dermatology calls lately psoriasis – and we have gotten some VERY positive feedback from them - could be a $500 million to a billion dollar drug in psoriasis alone. Getting paid for Apremilast may be 2013 – 2014 - but perhaps earlier with a very favorable deal with a major player in the dermatology space.
    Good downside support – even if for some reason MM-020 doesn’t go well, they still will make $9 EPS in 2015.

114.45+0.01(+0.01%)Jun 1 4:00 PMEDT